These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3488778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
    Dillman RO, Beauregard J, Shawler DL, Halpern SE, Markman M, Ryan KP, Baird SM, Clutter M.
    J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
    [Abstract] [Full Text] [Related]

  • 4. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T, Laurent G, Caveriviere P, Rigal F, Delsol G.
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [Abstract] [Full Text] [Related]

  • 5. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
    Foss FM, Raubitscheck A, Mulshine JL, Fleisher TA, Reynolds JC, Paik CH, Neumann RD, Boland C, Perentesis P, Brown MR, Frincke JM, Lollo CP, Larson SM, Carrasquillo JA.
    Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
    [Abstract] [Full Text] [Related]

  • 6. Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy.
    Shawler DL, Beauregard J, Halpern SE, Baird SM, Dillman RO.
    Clin Immunol Immunopathol; 1986 Oct; 41(1):43-54. PubMed ID: 3488861
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
    Goldman-Leikin RE, Kaplan EH, Zimmer AM, Kazikiewicz J, Manzel LJ, Rosen ST.
    Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101.
    Shawler DL, Johnson DE, McCallister TJ, Bartholomew RM, Dillman RO.
    Clin Immunol Immunopathol; 1988 May; 47(2):219-29. PubMed ID: 3258212
    [Abstract] [Full Text] [Related]

  • 12. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines.
    Boven E, Lindmo T, Mitchell JB, Bunn PA.
    Blood; 1986 Feb; 67(2):429-35. PubMed ID: 2417645
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.
    Rosen ST, Zimmer AM, Goldman-Leikin R, Gordon LI, Kazikiewicz JM, Kaplan EH, Variakojis D, Marder RJ, Dykewicz MS, Piergies A.
    J Clin Oncol; 1987 Apr; 5(4):562-73. PubMed ID: 3549989
    [Abstract] [Full Text] [Related]

  • 14. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.
    Maloney DG, Grillo-López AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R.
    Blood; 1997 Sep 15; 90(6):2188-95. PubMed ID: 9310469
    [Abstract] [Full Text] [Related]

  • 15. Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Fukunaga Y, Evans SS, Yamamoto M, Ueda Y, Tamura K, Takakuwa T, Gebhard D, Allopenna J, Demaria S, Clarkson B.
    Blood; 1989 Nov 15; 74(7):2486-92. PubMed ID: 2553165
    [Abstract] [Full Text] [Related]

  • 16. Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
    Dillman RO, Shawler DL, Dillman JB, Royston I.
    J Clin Oncol; 1984 Aug 15; 2(8):881-91. PubMed ID: 6379121
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen.
    Schroff RW, Klein RA, Farrell MM, Stevenson HC.
    J Immunol; 1984 Oct 15; 133(4):2270-7. PubMed ID: 6236264
    [Abstract] [Full Text] [Related]

  • 19. Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patients.
    Laurent G, Pris J, Farcet JP, Carayon P, Blythman H, Casellas P, Poncelet P, Jansen FK.
    Blood; 1986 Jun 15; 67(6):1680-7. PubMed ID: 3085747
    [Abstract] [Full Text] [Related]

  • 20. Imaging and dosimetry determinations using radiolabeled antibodies.
    Carrasquillo J.
    Cancer Treat Res; 1993 Jun 15; 68():65-97. PubMed ID: 8105853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.